Search - tctmd.com

Displaying 481 - 500 of 778

Sort: Relevancy | Date

Presentation Controversies and Advances 2017

Rise, Fall And Resurrection of Renal Denervation

Presenter: Michael A. Weber

November 16, 2017

News Opinion Off Script TCT 2017

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Kwan S. Lee

November 01, 2017

Presentation TCT 2017

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use CON!

Presenter: Nick Curzen, Fausto Feres, Simon Redwood

November 01, 2017

Presentation TCT 2017

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use PRO!

Presenter: Nick Curzen, Fausto Feres, Robert F. Riley

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

News Conference News TCT 2017

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Shelley Wood

November 01, 2017

Presentation TCT 2017

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Presenter: Navin K. Kapur, Jeffrey W. Moses, James M. McCabe

October 31, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

Presentation TCT 2017

Algorithms Within Algorithms: Lessons Learned From an Advanced CHIP Fellowship

Presenter: Alaide Chieffo, Jonathan M. Hill, Robert F. Riley

October 31, 2017

Presentation TCT 2017

Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers

Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham

October 30, 2017

Presentation TCT 2017

Topic 2: Outcomes Without a Clear Mechanism (Radial Mortality Benefit, Aspirin/Ticagrelor Interaction, and More)

Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

Alternatives to Traditional P-value Testing: Bayesian Designs

Presenter: Eugene H. Blackstone, Stuart J. Pocock, Roseann M White

October 30, 2017

Presentation TCT 2017

Beyond Time-to-First Event: Counting Multiple Events, Hierarchical Measures, and Weighted Composites

Presenter: Eugene H. Blackstone, Stuart J. Pocock, Jan G. P. Tijssen

October 30, 2017

Presentation TCT 2017

Proper and Improper Interpretations of the P-value

Presenter: Eugene H. Blackstone, Stuart J. Pocock

October 30, 2017

Presentation TCT 2017

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Stuart J. Pocock

October 30, 2017

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

Presentation TCT 2017

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Sanjay Kaul

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Advertisement

Rise, Fall And Resurrection of Renal Denervation

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use CON!

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use PRO!

Live From Denver: TCT 2017, Day Three

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Off Script: Focusing on the Future

Algorithms Within Algorithms: Lessons Learned From an Advanced CHIP Fellowship

Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Topic 2: Outcomes Without a Clear Mechanism (Radial Mortality Benefit, Aspirin/Ticagrelor Interaction, and More)

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Alternatives to Traditional P-value Testing: Bayesian Designs

Beyond Time-to-First Event: Counting Multiple Events, Hierarchical Measures, and Weighted Composites

Proper and Improper Interpretations of the P-value

Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others)

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others)

Live From Denver: TCT 2017, Day One

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content